China Newsbase
Fast, easy search of the China news that matters
The China News Database was last updated at 01:50PM on November 9, 2023.
Database searches currently perform best when a tag filter is used. We suggest trying out these tags: Xi Jinping, Russia, Taiwan, COVID-19, climate change, electric vehicles, gaming, IPOs, Belt and Road Initiative.
You may also filter by articles featured in our daily members-only Access newsletter, to get a curated overview of the top news and analysis about Chinese politics, business, and society. Select one option:
- All top news and analysis
- The China Project top news and analysis
- Top news and analysis from elsewhere — Stories in the “News briefing,” previously known as “Recommended links”
This product is in beta testing and development. If you would like to share feedback on the content or user experience, please email editors@thechinaproject.com.
209 articles matching the search query.
China's Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly
Chinese firm Sinovac Biotech Ltd said on Monday its coronavirus vaccine candidate appeared to be safe for older people, according to preliminary results from an early to mid-stage trial, while the immune responses triggered by the vaccine were slightly weaker than...
WHO says working with China on requirements for COVID vaccine approval
The World Health Organization is working with China on requirements for international approval of any Chinese COVID-19 vaccine, a senior official said on Monday.
Exclusive: 90% of China's Sinovac employees, families took coronavirus vaccine, says CEO
About 90% of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country's emergency use program, its chief executive said on Sunday.
Scientists see downsides to top COVID-19 vaccines from Russia, China
(This August 31 story is refiled to add dropped word founding to Ertl's title in paragraph 13)
WSJ News Exclusive | Chinese Covid-19 Vaccine Maker in Talks With Countries on Early Approval
CanSino is in talks with several countries to secure emergency approval for an experimental coronavirus vaccine before large-scale safety and effectiveness trials are completed, according to a company executive.
Sinovac's coronavirus vaccine candidate approved for emergency use in China - source
Sinovac Biotech Ltd's coronavirus vaccine candidate CoronaVac was approved for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.
China's Sinovac enters supply deal with Indonesia for COVID-19 vaccine doses
Sinovac Biotech Ltd said on Tuesday it would help Indonesia's state-owned drugmaker Bio Farma produce in the country at least 40 million doses of its potential coronavirus vaccine before March 2021.
Turkey in talks with Germany, China, Russia on vaccine trials
Turkey is in talks with Russia, Germany and China about conducting Phase 3 trials for coronavirus vaccines developed in those countries, Health Minister Fahrettin Koca said on Wednesday.
WSJ News Exclusive | China to Supply Coronavirus Vaccine to Pakistan
China will supply coronavirus vaccines to Pakistan as part of an agreement for vaccine trials to take place in the South Asian nation, according to Pakistani government officials
Mexico to trial China, U.S. COVID-19 vaccines, may produce some
Mexico aims to conduct late-stage clinical trials for COVID-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday.
AstraZeneca in first COVID-19 vaccine deal with Chinese company
Shenzhen Kangtai Biological Products will produce AstraZeneca Plc's potential COVID-19 vaccine in mainland China, the British drugmaker said on Thursday, its first deal to supply one of the world's most populous countries.
China rejects accusations of hacking attempt on U.S. vaccine developer Moderna
China rejected on Friday charges that hackers linked to its government targeted biotech firm Moderna Inc, a leading U.S.-based coronavirus vaccine research developer, to steal data.
Biocad discussing potential COVID-19 vaccine production in China
Biotech group Biocad is discussing producing in China a potential COVID-19 vaccine being developed by Russia's Vector state virology institute, the director of the St Petersburg-based company said in an interview.
China's Sinopharm begins late stage trial of COVID-19 vaccine in UAE
Chinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Abu Dhabi using up to 15,000 volunteers, the government in the capital of the United Arab Emirates said on Thursday.
China's CanSino in talks for COVID-19 vaccine Phase III trial overseas
Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday.
WSJ News Exclusive | U.S. National Security Panel Examining Chinese Investors’ Purchase of Pharma Firm
The inquiry focuses on the 2017 acquisition of South Carolina-based Ritedose after national-security officials learned it was in talks with the Pentagon over a project involving injection devices for a coronavirus vaccine.
WHO doesn't see bubonic plague in China as high risk: spokeswoman
An apparent outbreak of bubonic plague in China is being "well managed" and is not considered to represent a high risk, a World Health Organization (WHO) official said on Tuesday.
China to Fast-Track Coronavirus Vaccine Trial Based on Advanced Genetics Technology
A research institute run by China’s military received approval to conduct human clinical trials of a new Covid-19 vaccine developed using so-called messenger RNA, in a notable breakthrough for China’s quickly developing pharmaceutical industry.
Chinese firm gets approval to begin human testing for potential coronavirus vaccine
China has approved a coronavirus vaccine candidate developed by Chongqing Zhifei Biological Products' unit to begin human testing, the company said in a filing on Tuesday.
Clover launches sixth Chinese COVID-19 vaccine trial
Clover Biopharmaceuticals became the sixth Chinese developer of a potential COVID-19 vaccine to move into human trials on Friday, launching a study in Australia that will test its vaccine with boosters.